Our goal is to deliver real-world results like significant cost and risk reduction
(PRWEB) January 27, 2014
Christie® Medical Holdings, Inc., a global leader in mobile vascular imaging systems, today announced that the companys near-infrared VeinViewer® product, the first and only full field digital, HD imaging vein illumination device on the market, was awarded a new innovative technology designation from Novation, the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members, affiliates of national health care alliances VHA Inc. and UHC, as well as Childrens Hospital Association, and Provista.
The significant designation is only provided to a small number of products that are already available on contract through Novation. As part of the October 2013 Novation Innovative Technology Expo, the products were thoroughly evaluated and reviewed by hospital member-led councils and found to have an incremental benefit over other products that improve patient care or reduce the risk of harm to patients and caregivers. The products are now designated with a new Innovative Technology icon in the Novation online contract catalog making them easy to identify.
We are pleased to be awarded the annual Innovative Technology Novation designation which further validates VeinViewers technology capabilities and substantial clinical benefit as a leading peripheral IV solution used in the care of patients, said Chris Schnee, general manager and vice president of sales and marketing, at Christie. Our goal is to deliver real-world results like significant cost and risk reduction through better IV first stick success and reduction of medically unneeded PICC lines. We also strive to help boost the much needed patient satisfaction scores tied to reimbursement.
In addition to evaluating new technologies not on contract, we are pleased to recognize products already on contract that meet the strenuous hospital member-based requirements to be considered through the Innovative Technology program, said Debbie Archer, director, procurement and innovative technology, Novation.
VeinViewer technology contributes to improved healthcare delivery process at institutions and has decreased unnecessary PICC line placements resulting in significant cost savings and vein preservation. It is the only vein illumination device that provides Pre-, During-, and Post-access benefits throughout the entire vascular access procedure, allowing confirmation of the refill of vessels, detection of hematomas and potential avoidance of infiltrations, and has been shown through clinical studies to increase both first stick success and patient satisfaction up to 100 percent.
VeinViewer technology was developed with the aid of the engineering capabilities and resources of parent company Christie Digital Systems, a leading global visual technology firm with more than 80 years of experience in the projection systems industry. VeinViewer uses harmless near-infrared light, DLP® technologies, and exclusive Active Vascular Imaging Navigation (AVIN) to provide the demanded Pre, During and Post-access (PDP) benefits. VeinViewer provides TrueView imaging accuracy in projected vein-widths, which is three to ten times more accurate than the competition, and technologies such as Df2 (Digital full field) to illuminate the only available real-time HD digital image of subcutaneous vasculature and blood patterns directly onto the skin surface. Although designed for assistance in IV starts and blood draws, VeinViewer has proven beneficial in spider and varicose vein treatment.
To learn more about Christie product offerings: VeinViewer Vision, VeinViewer VisionXTND and VeinViewer Flex, please visit our refreshed website at http://www.veinviewer.com.
About Novation, Winner of the Ethics Inside® Certification
Founded in 1998, Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members and affiliates of VHA Inc. and UHC, two national health care alliances, Children’s Hospital Association, an alliance of the nation’s leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, and Provista members used Novation contracts to purchase approximately $43 billion in 2012. Novation has earned the coveted Ethics Inside® Certification from Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance. Novation also was named on Ethisphere’s World’s Most Ethical Companies list, and is the only company in the health care industry to earn both distinctions for two consecutive years. To learn more about Novation, please visit http://www.novationco.com and follow @NovationNews.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis, Tennessee, that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit http://www.christiemed.com.
Christie Public Relations
Mobile – 519.572.5824
Follow us on Twitter @christiemed
Christie® is a trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.
DLP® is a registered trademark of Texas Instruments.